Sawtooth Solutions LLC lifted its holdings in Cigna Corp (NYSE:CI) by 12.1% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 2,531 shares of the health services provider’s stock after purchasing an additional 273 shares during the period. Sawtooth Solutions LLC’s holdings in Cigna were worth $407,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also made changes to their positions in the company. 1 North Wealth Services LLC acquired a new position in Cigna during the 4th quarter valued at approximately $25,000. Clarfeld Financial Advisors LLC acquired a new position in Cigna during the 4th quarter valued at approximately $25,000. Delta Asset Management LLC TN acquired a new position in Cigna during the 4th quarter valued at approximately $28,000. Litman Gregory Asset Management LLC acquired a new stake in shares of Cigna in the fourth quarter worth $30,000. Finally, Parisi Gray Wealth Management acquired a new stake in shares of Cigna in the fourth quarter worth $32,000. 88.18% of the stock is owned by hedge funds and other institutional investors.
CI has been the topic of several analyst reports. ValuEngine upgraded shares of Cigna from a “sell” rating to a “hold” rating in a research report on Wednesday, March 20th. Zacks Investment Research downgraded shares of Cigna from a “hold” rating to a “sell” rating in a report on Tuesday, April 9th. Barclays decreased their price objective on shares of Cigna from $220.00 to $207.00 and set an “overweight” rating on the stock in a report on Wednesday, April 17th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $245.00 price objective on shares of Cigna in a report on Sunday, April 21st. Finally, UBS Group began coverage on shares of Cigna in a report on Tuesday, April 23rd. They set a “buy” rating and a $185.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and fourteen have issued a buy rating to the company. Cigna presently has a consensus rating of “Buy” and an average price target of $223.15.
Cigna (NYSE:CI) last issued its earnings results on Thursday, May 2nd. The health services provider reported $3.90 EPS for the quarter, topping analysts’ consensus estimates of $3.74 by $0.16. Cigna had a net margin of 4.11% and a return on equity of 14.23%. The company had revenue of $33.43 billion for the quarter, compared to the consensus estimate of $32.79 billion. During the same period in the previous year, the firm earned $4.11 earnings per share. Cigna’s quarterly revenue was up 192.9% compared to the same quarter last year. Sell-side analysts forecast that Cigna Corp will post 16.56 EPS for the current year.
Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.
Featured Story: Bar Chart
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.